Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00091637 · ClinicalTrials.gov registry record · Phase 3
Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)
A Phase 3 study, sponsored by Procter and Gamble.
- Completed
- Registry status
- Phase 3
- Development phase
- 5,745
- Enrollment target
NCT00091637: Completed Phase 3 study, sponsored by Procter and Gamble.
NCT00091637 is a Phase 3 study that has completed, run by Procter and Gamble. The registered enrollment target is 5,745 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (644% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00091637, a Phase 3 study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 5,745 participants
- Enrollment target
Study Summary
In the setting of reperfusion therapy in an acute myocardial infarction using primary percutaneous intervention (PCI), the body's own inflammatory system involving the complement cascade may be harmful. This study will test the safety and efficacy of a novel complement inhibitor, pexelizumab to reduce mortality at 30 days.
Interventions
- DRUG Placebo infusion
- DRUG Pexelizumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,745 participants |
| Start Date | 2004-04 |
| Est. Completion | 2007-05 |
| Phase | Phase 3 |
What the finished NCT00091637 record still lists
NCT00091637 is an interventional study that assigns participants to a tested intervention. Its 5,745 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (644% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo infusion is the first listed.
NCT00091637 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00091637 about?
NCT00091637 is a clinical study titled "Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)". In the setting of reperfusion therapy in an acute myocardial infarction using primary percutaneous intervention (PCI), the body's own inflammatory system involving the complement cascade may be harmful. This study will test the safety and efficacy of a novel complement inhibitor, pexelizumab to redu...
What is the current status of trial NCT00091637?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 5,745 participants. The study started on 2004-04. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00091637?
The interventions under investigation include: Placebo infusion (DRUG), Pexelizumab (DRUG).
Who is sponsoring clinical trial NCT00091637?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00091637's enrollment target sits among peer trials
5,745 42nd of 2000 higher than 1,959 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04983875 · 5,708 participants · NA
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
- NCT06627335 · 5,621 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- NCT05636176 · 5,600 participants · Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
- NCT06981598 · 5,586 participants · NA
Prevention of Psychological Health Problems Via Integrated Operational Support
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia